SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 25.71+1.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1418)2/10/1999 2:49:00 PM
From: Anthony Wong  Read Replies (1) of 1722
 
02/10 03:33 Monsanto's Celebrex is No. 2 in prescriptions -WSJ

NEW YORK, Feb 10 (Reuters) - Monsanto Co.'s <MTC.N> arthritis pain
drug Celebrex generated prescriptions in its third week on the market at
more than six times those of cholesterol drug Lipitor at a comparable
stage, the Wall Street Journal said on Wednesday.

Celebrex produced 82,000 prescriptions in the week ended Sunday,
making it the second-fastest start for a new drug in recent years,
surpassing Lipitor, which had 13,100 prescriptions written in its third week
in 1997, according to a report by pharmaceutical information provider
NDC Health Information Services, the paper said.

Lipitor, which is co-marketed by Warner-Lambert Co. <WLA.N> and
Pfizer Inc. <PFE.N>, is expected to generate $3.1 billion in sales this year,
the paper said.

Celebrex's sales are exceeded only by those of Pfizer impotence drug
Viagra, which sold 224,100 prescriptions in its third week, the paper said.

Pfizer is also co-marketing Celebrex with Monsanto.

Monsanto shares fell 11/16 to 45-1/8 and Pfizer shares fell 6-1/8, to
125-1/4 in New York Stock Exchange trade Tuesday, a day the Dow
Jones Industrials lost 1.70 percent falling 158.08 to 9133.03.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News